妊娠24周及以后羊膜腔穿刺:一项国际多中心研究
该国际多中心回顾性队列研究纳入2011至2022年9个转诊中心752例在24周0天至36周6天行羊膜腔穿刺的孕妇,主要指征为结构异常(91.6%),诊断率22.9%,术后2周内并发症率1.2%,24至28周与28至32周穿刺者的早产率无显著差异。
要点
- 晚孕期羊膜腔穿刺主要针对结构异常(91.6%),总体诊断率22.9%。
- 多器官系统异常胎儿诊断率36.4%,高于单器官系统异常的15.3%。
- 术后2周内总体并发症率1.2%,24至28周与28至32周穿刺早产率无显著差异。
核心结论
- 妊娠24周及以后羊膜腔穿刺,尤其对合并多发性先天异常的妊娠,诊断率高且并发症率低,凸显其临床实用性。
- 该检查可在分娩前为孕妇及其医生提供全面的诊断评估和结果,有助于知情咨询及优化围产期和新生儿护理计划。
研究设计与样本
- 国际多中心回顾性队列研究,纳入2011年至2022年9个转诊中心在24周0天至36周6天行产前诊断性羊膜腔穿刺的孕妇。
- 纳入有结局记录的单胎或双胎妊娠,排除孕期接受其他侵入性操作或羊膜腔穿刺用于产科指征者,共752例。
主要发现
- 晚孕期羊膜腔穿刺主要用于结构异常的产前诊断(91.6%),其次为疑似胎儿感染(2.3%)和游离DNA筛查高风险发现(1.9%)。
- 穿刺时中位孕周为28周5天,98.3%的孕妇在分娩或终止妊娠前获得基因检测结果。
- 总体诊断率为22.9%;多器官系统异常胎儿诊断率36.4%,单器官系统异常胎儿为15.3%,前者约为后者的2.4倍。
- 单器官系统或单一病变受累时,肌肉骨骼异常(36.7%)和胎儿水肿(36.4%)诊断率最高。
- 最常见的遗传诊断为非整倍体(46.8%),其次为拷贝数变异(26.3%)和单基因病(22.2%);分娩中位孕周为38周3天,穿刺至分娩平均59天;术后2周内总体并发症率为1.2%;24至28周与28至32周穿刺者的早产率无显著差异。
临床怎么用
- 原文结论指出,晚孕期羊膜腔穿刺尤其对多发性先天异常妊娠具有较高诊断率和较低并发症率,可在分娩前提供全面诊断评估以支持知情咨询和围产期护理规划。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Amniocentesis for genetic diagnosis is most commonly done between 15 and 22 weeks of gestation but can be performed at later gestational ages. The safety and genetic diagnostic accuracy of amniocentesis have been well-established through numerous large-scale multicenter studies for procedures before 24 weeks, but comprehensive data on late amniocentesis remain sparse. OBJECTIVE: To evaluate the indications, diagnostic yield, safety, and maternal and fetal outcomes associated with amniocentesis performed at or beyond 24 weeks of gestation. STUDY DESIGN: We conducted an international multicenter retrospective cohort study examining pregnant individuals who underwent amniocentesis for prenatal diagnostic testing at gestational ages between 24w0d and 36w6d. The study, spanning from 2011 to 2022, involved 9 referral centers. We included singleton or twin pregnancies with documented outcomes, excluding cases where other invasive procedures were performed during pregnancy or if amniocentesis was conducted for obstetric indications. We analyzed indications for late amniocentesis, types of genetic tests performed, their results, and the diagnostic yield, along with pregnancy outcomes and postprocedure complications. RESULTS: Of the 752 pregnant individuals included in our study, late amniocentesis was primarily performed for the prenatal diagnosis of structural anomalies (91.6%), followed by suspected fetal infection (2.3%) and high-risk findings from cell-free DNA screening (1.9%). The median gestational age at the time of the procedure was 28w5d, and 98.3% of pregnant individuals received results of genetic testing before birth or pregnancy termination. The diagnostic yield was 22.9%, and a diagnosis was made 2.4 times more often for fetuses with anomalies in multiple organ systems (36.4%) compared to those with anomalies in a single organ system (15.3%). Additionally, the diagnostic yield varied depending on the specific organ system involved, with the highest yield for musculoskeletal anomalies (36.7%) and hydrops fetalis (36.4%) when a single organ system or entity was affected. The most prevalent genetic diagnoses were aneuploidies (46.8%), followed by copy number variants (26.3%) and monogenic disorders (22.2%). The median gestational age at delivery was 38w3d, with an average of 59 days between the procedure and delivery date. The overall complication rate within 2 weeks postprocedure was 1.2%. We found no significant difference in the rate of preterm delivery between pregnant individuals undergoing amniocentesis between 24 and 28 weeks and those between 28 and 32 weeks, reinforcing the procedure's safety across these gestational periods. CONCLUSION: Late amniocentesis, at or after 24 weeks of gestation, especially for pregnancies complicated by multiple congenital anomalies, has a high diagnostic yield and a low complication rate, underscoring its clinical utility. It provides pregnant individuals and their providers with a comprehensive diagnostic evaluation and results before delivery, enabling informed counseling and optimized perinatal and neonatal care planning.
引用
- Zemet R, Maktabi MA, Tinfow A, et al. Amniocentesis in pregnancies at or beyond 24 weeks: an international multicenter study. Am J Obstet Gynecol. 2024. PMID: 38914189. doi:10.1016/j.ajog.2024.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。